In June, Maryland became the 1st state to pass a law in an attempt to ban price gouging by generic pharmaceutical manufacturers. The bill passed without the governor’s signature, who took issue with the bill’s language. Governor Larry Hogan said that his chief counsel raised legal and constitutional concerns about the bill.
Now, generic drug manufacturers in the Association for Accessible Medicines have taken those claims to court. The generic drug trade group filed suit in a federal court, seeking declaratory and injunctive relief against the implementation and enforcement of the law.